TechCrunch Podcast Covers BioticsAI's FDA Approval Path

TechCrunch released a new episode of its Build Mode podcast on April 30, 2026, featuring Robhy Bustami, co-founder and CEO of BioticsAI. The episode, hosted by Isabelle Johannessen, explores BioticsAI's path to FDA clearance for its AI copilot designed to detect fetal abnormalities via ultrasound.

@techcrunch reported that the discussion highlighted maintaining team momentum during the uncertain FDA approval process.

BioticsAI, which won the Startup Battlefield at TechCrunch Disrupt 2023, began with a $100,000 prototype. Bustami shared insights on navigating regulations in the medtech industry, where rapid iteration is limited and milestones require extensive coordination.

The conversation emphasized the importance of cross-functional collaboration among engineers, clinicians and researchers, as well as finding investors attuned to the sector's high risks and slower timelines.

Isabelle Johannessen, head of the Startup Battlefield Program at TechCrunch, hosted the episode. She holds a master’s degree in Entrepreneurship & Disruptive Innovation and previously led international startup acceleration programs in Japan, Korea, Italy and Spain. Johannessen scouts early-stage companies across more than 99 countries, preparing them to pitch at Disrupt events.

The episode was produced and edited by Maggie Nye, a senior audio producer for TechCrunch based in Denver, Colorado. Nye previously served as brand and content manager for BUILT BY GIRLS and holds a bachelor’s degree in Journalism with a minor in English from Hofstra University in New York. Audience development for the podcast was led by Morgan Little.